These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
163 related items for PubMed ID: 3993534
21. Efficacy and tolerability of losartan potassium and atenolol in patients with mild to moderate essential hypertension. Dahlöf B, Keller SE, Makris L, Goldberg AI, Sweet CS, Lim NY. Am J Hypertens; 1995 Jun; 8(6):578-83. PubMed ID: 7662242 [Abstract] [Full Text] [Related]
22. Comparison of acebutolol and hydrochlorothiazide in essential hypertension. Lewis JE. Am Heart J; 1985 May; 109(5 Pt 2):1168-74. PubMed ID: 2859781 [Abstract] [Full Text] [Related]
23. Amlodipine versus atenolol in essential hypertension. Frishman WH, Brobyn R, Brown RD, Johnson BF, Reeves RL, Wombolt DG. Am J Cardiol; 1994 Jan 27; 73(3):50A-54A. PubMed ID: 8310977 [Abstract] [Full Text] [Related]
24. Quinapril versus atenolol in the treatment of mild to moderate essential hypertension. Bahena JH, Estrella ME, Muñoz M. Clin Ther; 1992 Jan 27; 14(4):527-36. PubMed ID: 1525787 [Abstract] [Full Text] [Related]
25. A dose-response study of atenolol in mild to moderate hypertension in general practice. Gostick NK, Mayhew SR, Million R, Sagar D, Suxena SR, Ingram DF, Barmer NP. Curr Med Res Opin; 1977 Jan 27; 5(2):179-84. PubMed ID: 340136 [Abstract] [Full Text] [Related]
26. Multicentre comparison of the antihypertensive effect of acebutolol and hydrochlorothiazide in uncomplicated mild-moderate hypertension in the elderly. Salvetti A, Lucchini M, Airoldi G, Cagianelli MA, Cinotti G, Cortese R, Diamanti G, Giuntoli F, Pedrinelli R, Pettinà G. Eur J Clin Pharmacol; 1985 Jan 27; 29(3):275-9. PubMed ID: 3908126 [Abstract] [Full Text] [Related]
27. Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol. Frick MH, Kala R. Am J Cardiol; 1981 Nov 27; 48(5):911-6. PubMed ID: 6118059 [Abstract] [Full Text] [Related]
28. Nifedipine and atenolol singly and combined for treatment of essential hypertension: comparative multicentre study in general practice in the United Kingdom. Nifedipine-Atenolol Study Review Committee. Nifedipine-Atenolol Study Review Committee. Br Med J (Clin Res Ed); 1988 Feb 13; 296(6620):468-72. PubMed ID: 2894883 [Abstract] [Full Text] [Related]
29. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension. Ott P, Storm TL, Krusell LR, Jensen H, Badskjaer J, Faergeman O. Am J Cardiol; 1987 May 29; 59(14):73G-77G. PubMed ID: 2884856 [Abstract] [Full Text] [Related]
30. A double-blind comparison of bisoprolol and atenolol in patients with essential hypertension. Wheeldon NM, MacDonald TM, Prasad N, Maclean D, Peebles L, McDevitt DG. QJM; 1995 Aug 29; 88(8):565-70. PubMed ID: 7648243 [Abstract] [Full Text] [Related]
31. A randomized crossover comparison of acebutolol and methyldopa in the treatment of mild to moderate essential hypertension. Chatterji AN. Curr Med Res Opin; 1978 Aug 29; 5(9):675-81. PubMed ID: 367712 [Abstract] [Full Text] [Related]
33. Comparison of diltiazem and atenolol in young, physically active men with essential hypertension. Myburgh DP, Gordon NF. Am J Cardiol; 1987 Nov 01; 60(13):1092-5. PubMed ID: 3314458 [Abstract] [Full Text] [Related]
37. [Comparison of the anti-hypertensive effects of combinations of nifedipine retard with acebutolol or atenolol]. da Costa PS, de Moraes LB, Costa AG. Arq Bras Cardiol; 1984 Oct 01; 43(4):279-82. PubMed ID: 6399201 [No Abstract] [Full Text] [Related]
38. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension. Pandhi P, Sethi V, Sharma BK, Wahl PL, Sharma PL. Int J Clin Pharmacol Ther Toxicol; 1985 Nov 01; 23(11):606-8. PubMed ID: 3908332 [Abstract] [Full Text] [Related]